Market Overview & Size
The global pharmaceutical CDMO industry has moved well past its early role as a low-cost manufacturing backup option — it is now a structural pillar of how new drugs reach patients. According to Grand View Research, the market was valued at USD 166.0 billion in 2025 and is estimated to reach USD 177.6 billion in 2026. From there, it is projected to climb to USD...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek